Preview

Title in english

Advanced search

Gender features of metabolic syndrome components in young age

https://doi.org/10.34680/2076-8052.2023.4(133).565-575

Abstract

The article analyzes the clinical and laboratory features of young men and women with abdominal obesity and metabolic syndrome. The study was carried out on 173 patients of both sexes aged 18-45 years. The patients were divided into 3 groups: group 1 – isolated abdominal obesity (AO); group 2 – combination of abdominal obesity with 1 of the metabolic syndrome components (AO+1); group 3 – metabolic syndrome (MetS). It was found that in young men, the values of carbohydrate (glucose, insulin) and lipid metabolism (HDL cholesterol, LDL cholesterol, triglycerides), insulin resistance indices (HOMA-IR, TyG) in the AO and AO+1 groups were homogeneous. However, the ratio of TG/HDL in the AO+1 group exceeded the value of the AO group. Women in the AO+1 group showed changes relative to the group of women with isolated AO that are hyperglycemia, increased LDL cholesterol, insulin resistance (increased TG/HDL) and dysfunction of visceral adipose tissue (increased VAI). Young men with MetS are characterized by excess body weight, hyperglycemia, dyslipidemia (increased LDL cholesterol and triglycerides), insulin resistance (as measured by TyG and TG/HDL), and dysfunction of visceral adipose tissue. The gender feature of women is the development of MetS on the background of obesity, dysfunction of visceral adipose tissue and insulin resistance in combination with deeper changes in lipid metabolism (increased LDL cholesterol and triglycerides, as well as a decrease in HDL cholesterol).

About the Authors

V. A. Sumerkina
South Ural State Medical University
Russian Federation

Chelyabinsk



V. S. Chulkov
Yaroslav-the-Wise Novgorod State University
Russian Federation

Veliky Novgorod



E. S. Golovneva
South Ural State Medical University; Multidisciplinary Center of Laser Medicine
Russian Federation

Chelyabinsk



L. F. Telesheva
South Ural State Medical University
Russian Federation

Chelyabinsk



References

1. Pucci G., Alcidi R., Tap L., Battista F., Mattace-Raso F., Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature // Pharmacological Research. 2017. 120. 34-42. DOI: 10.1016/j.phrs.2017.03.008

2. Kitikova O. Yu., Antonyuk M. V., Kantur T. A., Novgorodtseva T. P., Denisenko Yu. K. Rasprostranennost' i biomarkery metabolicheskogo sindroma [Prevalence and biomarkers of metabolic syndrome] // Obesity and metabolism. 2021. 18(3). 302-312. DOI: 10.14341/omet12704

3. Obesity and overweight. Geneve. World Health Organization (WHO). 2021. Available at: https://www.who.int/newsroom/fact-sheets/detail/obesity-and-overweight (Accessed: 30.08.2023).

4. Shlyakhto E. V., Nedogoda S. V., Konradi A. O., Baranova E. I., Fomin V. V., Vertkin A. L., Chumakova G. A. Kontseptsiya novykh natsional'nykh klinicheskikh rekomendatsiy po ozhireniy [The concept of new national clinical guidelines on obesity] // Russian Journal of Cardiology. 2016.132(4). 7-13. DOI: 10.15829/1560-4071-2016-4-7-13

5. Ostrovskaya E. V., Romantsova T. I., Gerasimov A. V., Novoselova T. V. Rasprostranennost' metabolicheski zdorovogo ozhireniya po dannym vyborki Moskovskogo regiona [Prevalence of metabolically healthy obesity according to a sample of the Moscow region] // Obesity and metabolism. 2017. 14(4). 51-56. DOI: 10.14341/omet2017451-56

6. Larina N. G., Roitman T. I., Weber V. R., Pogrebnyak L. N., Secheneva L. V., Davydova T. A. Markery metabolicheskogo sindroma u podrostkov s konstitutsional'no- ekzogennym ozhireniyem [Markers of metabolic syndrome in adolescents with constitutionally exogenous obesity] // Vestnik NovSU. 2019. 3(115). 18-20. DOI: 10.34680/2076-8052.2019.3(115).18-20

7. Rekomendatsii po vedeniyu bol'nykh arterial'noy gipertoniyey s metabolicheskimi narusheniyami i sakharnym diabetom 2-go tipa [Recommendations for the management of patients with arterial hypertension with metabolic disorders and type 2 diabetes mellitus] // Systemic hypertension. 2020. 17(1). 7-45. DOI: 10.26442/2075082X.2020.1.200051

8. Regitz-Zagrosek V., Lehmkuhl E., Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease // Gender Medicine. 2007. 4(Suppl B). S162–S177. DOI: 10.1016/s1550-8579(07)80056-8


Review

For citations:


Sumerkina V.A., Chulkov V.S., Golovneva E.S., Telesheva L.F. Gender features of metabolic syndrome components in young age. Title in english. 2023;(4(133)):565-575. https://doi.org/10.34680/2076-8052.2023.4(133).565-575

Views: 41


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2076-8052 (Print)